Literature DB >> 26056539

Progress in research into the genes associated with venous thromboembolism.

Lian-Xing Zhao1, Bo Liu1, Chun-Sheng Li1.   

Abstract

BACKGROUND: Venous thromboembolism (VTE), including both deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common, lethal disorder that affects hospitalized and non-hospitalized patients. This study aimed to review the progress in the research into VTE. DATA SOURCES: We reviewed the studies about VTE and verified different genetic polymoriphisms of VTE.
RESULTS: The pathogenesis of VTE involves hereditary and acquired factors. Many studies indicated that the disorder of coagulation and fibirnolytic system is of utmost importance to this disease. Genetic polymoriphism-related VTE demonstrated significant differences among geographies and ethnicities.
CONCLUSION: VTE has many risk factors, but genetic factors play an important role.

Entities:  

Keywords:  Gene; Hereditary; Polymoriphism; Venous thrombosis

Year:  2015        PMID: 26056539      PMCID: PMC4458468          DOI: 10.5847/wjem.j.1920-8642.2015.02.003

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  40 in total

1.  The prothrombin 3'end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations.

Authors:  Sven Danckwardt; Niels H Gehring; Gabriele Neu-Yilik; Patrick Hundsdoerfer; Margit Pforsich; Ute Frede; Matthias W Hentze; Andreas E Kulozik
Journal:  Blood       Date:  2004-04-01       Impact factor: 22.113

Review 2.  Advances in understanding pathogenic mechanisms of thrombophilic disorders.

Authors:  Björn Dahlbäck
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

3.  [A pedigree analysis of pulmonary embolism caused by compound heterozygous mutations of protein C].

Authors:  Xu Ye; Xiaoli Liu; Ying Feng; Qiulan Ding; Xuhong Zhou; Xuefeng Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2012-01

4.  The nitric oxide synthase 3 gene polymorphisms and their association with deep vein thrombosis in Asian Indian patients.

Authors:  Mohd Suhail Akhter; Arijit Biswas; Ravi Ranjan; Amit Sharma; Sunil Kumar; Renu Saxena
Journal:  Clin Chim Acta       Date:  2010-01-28       Impact factor: 3.786

5.  Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.

Authors:  J M Brugge; P Simioni; F Bernardi; D Tormene; B Lunghi; G Tans; A Pagnan; J Rosing; E Castoldi
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

6.  R147W mutation of PROC gene is common in venous thrombotic patients in Taiwanese Chinese.

Authors:  Woei Tsay; Ming-Ching Shen
Journal:  Am J Hematol       Date:  2004-05       Impact factor: 10.047

7.  Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

Authors:  D A Lane; R J Olds; M Boisclair; V Chowdhury; S L Thein; D N Cooper; M Blajchman; D Perry; J Emmerich; M Aiach
Journal:  Thromb Haemost       Date:  1993-08-02       Impact factor: 5.249

8.  Hyperhomocysteinaemia, low folate concentrations and methylene tetrahydrofolate reductase C677T mutation in acute mesenteric venous thrombosis.

Authors:  J A He; X H Hu; Y Y Fan; J Yang; Z S Zhang; C W Liu; D H Yang; J Zhang; S J Xin; Q Zhang; Z Q Duan
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-10-20       Impact factor: 7.069

Review 9.  Regulation of TFPI function by protein S.

Authors:  T M Hackeng; L F A Maurissen; E Castoldi; J Rosing
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

10.  Copy number variations of the F8 gene are associated with venous thromboembolism.

Authors:  Wei Shen; Yi Gu; Rui Zhu; Lan Zhang; Jiwei Zhang; Chunmei Ying
Journal:  Blood Cells Mol Dis       Date:  2013-02-09       Impact factor: 3.039

View more
  1 in total

1.  Challenges imposed by minor reference alleles on the identification and reporting of clinical variants from exome data.

Authors:  Mahmoud Koko; Mohammed O E Abdallah; Mutaz Amin; Muntaser Ibrahim
Journal:  BMC Genomics       Date:  2018-01-15       Impact factor: 3.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.